Also known as samsung biologics
Samsung Biologics is a corporate investor based in Incheon, South Korea. Founded in 2011. Reported AUM: 9052 USD millions.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
Samsung Biologics is a corporate investor based in Incheon, South Korea, managing approximately $9.1B in assets.
Samsung Biologics is headquartered in Incheon, South Korea.
Samsung Biologics manages approximately $9.1B in assets under management.
Samsung Biologics was founded in 2011.
Samsung Biologics focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General), Biotechnology, Healthcare, Pharmaceuticals.
Verified contact details, key decision-makers, and investment preferences for Samsung Biologics are available on LPbacked. Create a free account to access them.